SC Pharmaceuticals Inc (SCPH) Stock Price, Quote & News

Company Profile

scPharmaceuticals Inc., a pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for the treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresi...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 517 0730

Website: www.scpharmaceuticals.com

Address:

25 Mall Road, Suite 203, Burlington, United States

clan Oct. 24 at 1:30 AM

$MNKD $SCPH This is going to make Mannkind Corp. 100s of MILLION$ in PROFITS over the coming years!

0 · Reply

clan Oct. 8 at 11:48 PM

$MNKD $SCPH $UTHR $BX "Synergies", "growing revenues", record revenues", "expanded product offerings", "advancing pipeline","strong financials" 🐂

0 · Reply

BDE_Worldwide Oct. 8 at 6:48 PM

$SCPH speak of the devil.. cash just hit Schwab..

1 · Reply

BDE_Worldwide Oct. 8 at 5:32 PM

$SCPH wondering when cash will settle in our accounts..

0 · Reply

nomalarkey Oct. 7 at 5:31 PM

$MNKD who from the $SCPH board is now here watching us loonies on the Mannkind board now that you are part of our dysfunctional family?

0 · Reply

clan Oct. 7 at 3:39 PM

$MNKD It appears we have another not uncommon response to a morning Mannkind news event that will require the evening headline readers to find out about the positiveness and then buy the next day. Look for a higher MNKD tomorrow (as well). Those who were in $SCPH , roll your $5.35/sh into MNKD now @$5.65/sh.

1 · Reply

Nt714 Oct. 7 at 3:17 PM

$SCPH anyone knows what will happen to my call option of scph thats in the money? I cant even sell it now, they wont let me.

0 · Reply

Nt714 Oct. 7 at 3:15 PM

$SCPH anyone knows what will happen to my call option of scph thats in the money?

1 · Reply

TwongStocks Oct. 7 at 1:03 PM

$MNKD MannKind Completes Acquisition of scPharmaceuticals $SCPH, Accelerating Revenue Growth in Cardiometabolic Care https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-completes-acquisition-scpharmaceuticals-accelerating

0 · Reply

clan Oct. 7 at 12:44 PM

$MNKD Mannkind now owns scPharma $SCPH and Furoscix.

0 · Reply

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

MNKD

Aug 25, 2025, 7:31 AM EDT - 2 months ago

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

Aug 14, 2025, 8:30 AM EDT - 2 months ago

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

Aug 8, 2025, 2:09 PM EDT - 2 months ago

scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:01 PM EDT - 2 months ago

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 31, 2025, 4:01 PM EDT - 3 months ago

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

May 22, 2025, 7:29 AM EDT - 5 months ago

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025

May 15, 2025, 12:15 AM EDT - 5 months ago

scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:01 PM EDT - 5 months ago

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

May 7, 2025, 4:01 PM EDT - 6 months ago

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025

May 1, 2025, 4:01 PM EDT - 6 months ago

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Mar 19, 2025, 7:13 PM EDT - 7 months ago

scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:01 PM EDT - 7 months ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 12, 2025, 4:01 PM EDT - 8 months ago

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

Mar 6, 2025, 4:01 PM EST - 8 months ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

Feb 26, 2025, 4:01 PM EST - 8 months ago

scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences

Feb 5, 2025, 4:01 PM EST - 9 months ago

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 10, 2025, 8:00 AM EST - 10 months ago

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

Nov 13, 2024, 7:05 PM EST - 1 year ago

scPharmaceuticals Inc. (SCPH) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

Oct 15, 2024, 8:30 AM EDT - 1 year ago

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

Aug 15, 2024, 5:10 AM EDT - 1 year ago

scPharmaceuticals Inc. (SCPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 12, 2024, 9:48 AM EDT - 1 year ago

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering

Aug 12, 2024, 6:05 AM EDT - 1 year ago

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors

Aug 12, 2024, 6:04 AM EDT - 1 year ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure

Aug 12, 2024, 6:02 AM EDT - 1 year ago

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector

Aug 12, 2024, 6:00 AM EDT - 1 year ago

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

May 29, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 14, 2024, 7:02 PM EDT - 1 year ago

scPharmaceuticals Inc. (SCPH) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

May 13, 2024, 4:05 PM EDT - 1 year ago

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 7, 2024, 4:05 PM EDT - 1 year ago

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Apr 24, 2024, 8:00 AM EDT - 1 year ago

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Mar 13, 2024, 7:32 PM EDT - 1 year ago

scPharmaceuticals Inc (SCPH) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Mar 6, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

Feb 28, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

Jan 4, 2024, 4:05 PM EST - 1 year ago

scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue

Nov 12, 2023, 2:57 AM EST - 2 years ago

scPharmaceuticals Q3 Earnings: Cruising Toward Success

Nov 8, 2023, 9:58 PM EST - 2 years ago

scPharmaceuticals Inc (SCPH) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:01 PM EST - 2 years ago

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 1, 2023, 4:05 PM EDT - 2 years ago

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

Oct 5, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 27, 2023, 12:40 AM EDT - 2 years ago

scPharmaceuticals: Furoscix, Charting A Bright Future With FDA's Nod For CKD

Sep 19, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

clan Oct. 24 at 1:30 AM

$MNKD $SCPH This is going to make Mannkind Corp. 100s of MILLION$ in PROFITS over the coming years!

0 · Reply

clan Oct. 8 at 11:48 PM

$MNKD $SCPH $UTHR $BX "Synergies", "growing revenues", record revenues", "expanded product offerings", "advancing pipeline","strong financials" 🐂

0 · Reply

BDE_Worldwide Oct. 8 at 6:48 PM

$SCPH speak of the devil.. cash just hit Schwab..

1 · Reply

BDE_Worldwide Oct. 8 at 5:32 PM

$SCPH wondering when cash will settle in our accounts..

0 · Reply

nomalarkey Oct. 7 at 5:31 PM

$MNKD who from the $SCPH board is now here watching us loonies on the Mannkind board now that you are part of our dysfunctional family?

0 · Reply

clan Oct. 7 at 3:39 PM

1 · Reply

Nt714 Oct. 7 at 3:17 PM

$SCPH anyone knows what will happen to my call option of scph thats in the money? I cant even sell it now, they wont let me.

0 · Reply

Nt714 Oct. 7 at 3:15 PM

$SCPH anyone knows what will happen to my call option of scph thats in the money?

1 · Reply

TwongStocks Oct. 7 at 1:03 PM

0 · Reply

clan Oct. 7 at 12:44 PM

$MNKD Mannkind now owns scPharma $SCPH and Furoscix.

0 · Reply

MITornado Oct. 6 at 11:25 PM

$SCPH been a pleasure … adios amigos.

0 · Reply

youspeaktome Oct. 6 at 4:37 PM

$SCPH remember to tender your shares today. today's the deadline

1 · Reply

clan Oct. 6 at 1:20 AM

$MNKD 🥸 $UTHR 👓 $SCPH 👀

0 · Reply

clan Oct. 4 at 9:37 AM

$MNKD The pieces to the Mannkind puzzle are coming together ... and it's makin' fer a pretty nice lookin' picture!🧩💲🧩💲 $SCPH $UTHR $BX

2 · Reply

Tom678 Oct. 2 at 12:02 PM

$BCDA $DJT $PAVS $SCPH $TAOP BCDA amazing news !!!! 😁😁

0 · Reply

Zeroletdown Oct. 2 at 1:32 AM

$SCPH So bit confused. If I'm in the stock for the full payout, 3.35 plus extra $1, should I tender my shares at 5.35 And rest comes later? Or hold? Thx

2 · Reply

TwongStocks Oct. 1 at 6:48 PM

$SCPH NASDAQ Equity Corporate Actions Alert # 2025 - 542 Information Regarding the Tender Offer of scPharmaceuticals Inc. (SCPH) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-542 The tender offer by Seacoast Merger Sub, Inc. a direct wholly owned subsidiary of MannKind Corporation $MNKD to acquire all of the outstanding common stock of scPharmaceuticals Inc. (SCPH) is scheduled to expire one minute after 11:59 p.m. ET, on October 6, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on October 7, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on October 6, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (October 7, 2025) and will be suspended effective October 8, 2025. Tender offer: SCPH shareholders will receive $5.35 and one (1) Contingent Value Right (CVR) for each share held.

0 · Reply

nomalarkey Oct. 1 at 1:46 PM

uh, @StockHounding , $MNKD announced it was buying $SCPH back in August. How exactly did you miss that key news?

0 · Reply

clan Sep. 30 at 4:22 PM

$MNKD $SCPH More of this coming...

0 · Reply

clan Sep. 30 at 2:50 PM

$SCPH @neil36. With this stock selling at a current $0.31/sh premium to the tender offer of $5.35/sh ( by $MNKD ), it appears 'Vegas' odds are leaning toward all the current shareholders of scPharma will get the full $1 per CVR issued. A win-win-win for all. 💎👐

1 · Reply

clan Sep. 27 at 9:10 PM

$MNKD Expecting a couple October "Yabba Dabba Doo!" moments for Mannkind. 🎃👻 $SCPH $UTHR

0 · Reply

ChartChartist Sep. 27 at 5:28 PM

$SAVA downchannel gonna break retest $3.5 $SCPH looks tight $CCCX up $PAVS everyone’s going crazy slapping pavs i love to see it perfect setup be on it

1 · Reply

Market Cap	302.20M
Revenue (ttm)	36.33M
Net Income (ttm)	-85.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-234.38%
Debt to Equity Ratio	-2.40

Volume	10,898,600
Avg Vol	1,751,720
Day's Range	N/A - N/A
Shares Out	53.30M
Stochastic %K	63%
Beta	0.31
Analysts	Sell
Price Target	$11.84